Auray JP - Search Results

1

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.

Silverberg K, Daya S, Auray JP, Duru G, Ledger W, Wikland M, Bouzayen R, O'Brien M, Falk B, Beresniak A. Silverberg K, et al. Among authors: auray jp. Fertil Steril. 2002 Jan;77(1):107-13. doi: 10.1016/s0015-0282(01)02945-4. Fertil Steril. 2002. PMID: 11779599 Free article. Clinical Trial.

2

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system.

Romeu A, Balasch J, Ruiz Balda JA, Barri PN, Daya S, Auray JP, Duru G, Beresniak A, Peinado JA. Romeu A, et al. Among authors: auray jp. J Assist Reprod Genet. 2003 Aug;20(8):294-300. doi: 10.1023/a:1024899806149. J Assist Reprod Genet. 2003. PMID: 12948090 Free PMC article.

3

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK.

Daya S, Ledger W, Auray JP, Duru G, Silverberg K, Wikland M, Bouzayen R, Howles CM, Beresniak A. Daya S, et al. Among authors: auray jp. Hum Reprod. 2001 Dec;16(12):2563-9. doi: 10.1093/humrep/16.12.2563. Hum Reprod. 2001. PMID: 11726575

4

Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Beresniak A, Medina-Lara A, Auray JP, De Wever A, Praet JC, Tarricone R, Torbica A, Dupont D, Lamure M, Duru G. Beresniak A, et al. Among authors: auray jp. Pharmacoeconomics. 2015 Jan;33(1):61-9. doi: 10.1007/s40273-014-0216-0. Pharmacoeconomics. 2015. PMID: 25230587

5

On the choice of an organization for a pathology laboratory.

Auray JP, Collombel C, Duru G, Richard-Couturier L. Auray JP, et al. Soc Sci Med. 1985;21(10):1113-8. doi: 10.1016/0277-9536(85)90168-6. Soc Sci Med. 1985. PMID: 3936189

6

Clinically relevant differences and "Biocreep".

Auray JP, Duru G. Auray JP, et al. Fertil Steril. 2004 May;81(5):1423; author reply 1423-4. doi: 10.1016/j.fertnstert.2004.03.001. Fertil Steril. 2004. PMID: 15136119 Free article. No abstract available.

7

Limitations of the methods used for calculating quality-adjusted life-year values.

Duru G, Auray JP, Béresniak A, Lamure M, Paine A, Nicoloyannis N. Duru G, et al. Among authors: auray jp. Pharmacoeconomics. 2002;20(7):463-73. doi: 10.2165/00019053-200220070-00004. Pharmacoeconomics. 2002. PMID: 12093302

8

[Which measures are to be taken in the prevention of prematurity in working women?].

Mamelle N, Bertucat I, Auray JP, Duru G. Mamelle N, et al. Among authors: auray jp. Rev Epidemiol Sante Publique. 1986;34(4-5):286-93. Rev Epidemiol Sante Publique. 1986. PMID: 3823522 French.

9

Impact of pigmentary disorders on quality of life in Japan: Interest of the BeautyQoL instrument.

Beresniak A, Auray JP, Duru G, Aractingi S, Krueger GG, Talarico S, Adam AS, Piot B, Dupont D, de Linares Y. Beresniak A, et al. Among authors: auray jp. J Cosmet Laser Ther. 2015;17(6):313-7. doi: 10.3109/14764172.2015.1039034. Epub 2015 Jul 2. J Cosmet Laser Ther. 2015. PMID: 25968164

10

Quality of life assessment in cosmetics: specificity and interest of the international BeautyQol instrument.

Beresniak A, Auray JP, Duru G, Aractingi S, Krueger GG, Talarico S, Tsutani K, Dupont D, de Linares Y. Beresniak A, et al. Among authors: auray jp. J Cosmet Dermatol. 2015 Sep;14(3):260-5. doi: 10.1111/jocd.12156. Epub 2015 Jul 2. J Cosmet Dermatol. 2015. PMID: 26133392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page